4//SEC Filing
Roivant Sciences Ltd. 4
Accession 0001140361-25-045409
$ROIVCIK 0001764013operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:17 PM ET
Size
5.4 KB
Accession
0001140361-25-045409
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Roivant Sciences Ltd.
Director10% Owner
Transactions
- Purchase
Common Stock, $0.0001 par value per share
2025-12-12$21.00/sh+16,666,666$349,999,986→ 113,317,007 total
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeoperating
IncorporatedBermuda
Related Parties
1- filerCIK 0001635088
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:17 PM ET
- Size
- 5.4 KB